Quoin Pharmaceuticals Ltd. (QNRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading QNRX…

Quoin Pharmaceuticals Ltd. (QNRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Quoin Pharmaceuticals Ltd.

QNRX · CIK 1671502

4 · Aug 28, 2026 · Director Culverwell Anthony James was granted 31.35K ADSs at $5.15/unit ($161.5K)

4

Director Culverwell Anthony James was granted 31.35K ADSs at $5.15/unit ($161.5K)

Filed: Aug 28, 2026
Period: Aug 27, 2026
Accession: 0001104659-26-103374
Filer: Quoin Pharmaceuticals, Ltd.

View on SEC.gov All SEC filings

Filing document

OWNERSHIP DOCUMENT

xslF345X06/tm2624320-1_4seq1.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4OWNERSHIP DOCUMENTtm2624320-1_4seq1.xml
Open SEC.gov